The global market for lipids is experiencing growth due to several factors. The increasing prevalence of chronic diseases worldwide has created a higher demand for lipid-based therapies and treatments. Additionally, the rising healthcare expenditure aimed at improving health services has further added to market growth. Major market players are focusing on product promotions and drug approvals, improving the convenience of lipid-based products. Furthermore, the growing demand for lipids in diverse industries like food and beverage, cosmetics, and others is also fueling the overall demand for the lipid market.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-lipid-market
Data Bridge Market Research analyses that the Lipids Market is growing with a CAGR of 8.4% in the forecast period of 2023 to 2030 and is expected to reach USD 23,313.48 million by 2030 from USD 12,267.84 million in 2022. The increasing incidence of chronic diseases, such as cardiovascular diseases, obesity, and diabetes, has created a higher demand for lipid-based therapies and treatments. Lipids play a vital role in maintaining and improving health, making them essential in managing and preventing these conditions.
Key Findings of the Study
Increasing demand from various industries is expected to drive the market's growth rate
The increasing demand for lipids across various industries is driving the growth of the global lipids market. In the food and beverage sector, lipids are utilized for flavor enhancement, texture improvement, and as functional ingredients. In the pharmaceutical industry, lipids play a crucial role in drug delivery systems, enabling targeted and controlled release of medications. In cosmetics, lipids are utilized for their moisturizing and emollient properties. Additionally, lipids are essential in animal feed formulations to enhance nutrition and promote healthy growth. The diverse applications of lipids in these industries contribute to the overall market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Natural Lipids and Synthetic Lipids), Lipid System (Neutral Lipids, Bacterial Lipids, Fluorescent Lipids, Bioactive Lipids, Polymerizable Lipids, Headgroup Modified Lipids, and Others), Delivery System (Liposomes, Solid Lipid Nanoparticles, Nanostructures Lipid Carrier, Niosomes, Transferosomes, and Others), Source (Egg Yolk, Soyabean, Non-GMO Soyabean, Purified Oils, Purified Fatty Acids, and Others), End User (Pharmaceutical Industries, Biotechnology Industries, Academic and Research Institutes, Cosmetic Industries and Others), Distribution Channel (Direct Tender, Retail Sales and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Alnylam Pharmaceutical, Inc. (U.S.),Croda International Plc. (U.K.), Moderna Inc. (U.S.), BioNTech SE. (Germany), Pfizer Inc. (U.S.), Evonik Industries AG (Germany),Lipoid GmbH (Germany),Matreya LLC (U.S.), VAV Life Sciences Pvt Ltd. (India), Curia Global Inc. (U.S.), Cargill, Incorporated (U.S.),Gattefossé (France), CD Bioparticles (U.S.), Merck KGaA (Germany),NOF EUROPE GmbH (Japan),ABITEC (U.S.), Cayman Chemical (U.S.),CordenPharma International (Switzerland), CHEMI S.p.A. (Italy), DSM (Netherlands), BASF SE (Germany),Tokyo Chemical Industry Co., Ltd. (Japan), ADMSIO (South Korea.), Stepan Company (U.S.), Kerry (Ireland) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The lipids market is segmented on the basis of type, lipid systems, delivery systems, source, end user and distribution channel.
- On the basis of type, the global lipids market is segmented into natural lipids and synthetic lipids. The natural lipids segment is expected to dominate the global lipids market with a 56.92% market share and is expected to reach USD 13,354.73 million by 2030, growing with the CAGR of 8.5% in the forecast period of 2023 to 2030 due to lipid compounds that occur naturally in living organisms. Natural lipids are widely used in the food and beverage industry, pharmaceuticals, cosmetics, and other applications due to their biological compatibility, functional properties, and perceived health benefits.
- On the basis of lipid systems, the global lipids market is segmented into neutral lipids, bacterial lipids, fluorescent lipids, bioactive lipids, polymerizable lipids, headgroup modified lipids, and others. In 2023, the bioactive lipids segment is expected to dominate the global lipids market with a CAGR of 9.0% in the forecast period of 2023 to 2030 due to this type of lipid system having more demand for the drug development process.
In 2023, the bioactive lipids segment is expected to dominate the lipid systems of the global lipids market.
In 2023, the bioactive lipids segment is expected to dominate the global lipids market owing to the signaling molecules such as prostaglandins, sphingolipids, and endocannabinoids, which play crucial roles in cellular signaling and regulation of various biological processes with a CAGR of 9.0% in the forecast period of 2023 to 2030
- On the basis of the delivery system, the global lipids market is segmented into liposomes, solid lipid nanoparticles, nanostructurers lipid carriers, niosomes, transferosomes and others. In 2023, liposomes segment is expected to dominate the global lipids market with a CAGR of 9.4% in the forecast period of 2023 to 2030 due to encapsulating and deliver drugs or other active ingredients to targeted sites in the body
- On the basis of source, the global lipids market is segmented into egg yolk, soybean, non-GMO soybean, purified oils, purified fatty acids and others. Purified fatty acids segment is expected to dominate the global lipids market with a CAGR of 10.6% in the forecast period of 2023 to 2030 due to lipids taken from this source have various applications and advantages in drug delivery systems
- On the basis of end user, the global lipids market is segmented into pharmaceutical industries, biotechnology industries, academic and research institutes, cosmetic industries and others. In 2023, pharmaceutical industries segment is expected to dominate the global lipids market with a CAGR of 9.8% in the forecast period of 2023 to 2030 due to utilize lipids for drug delivery systems, formulation aids, lipid-based drugs, and targeting interactions.
In 2023, the pharmaceutical industries segment is expected to dominate the end user segment of the global lipids market
In 2023, the pharmaceutical industries segment is expected to dominate the global lipids market owing to end users that encompass companies engaged in the research, development, manufacturing, and distribution of pharmaceutical products, including drugs, medications, and medical devices with a CAGR of 9.8% in the forecast period of 2023 to 2030.
- On the basis of distribution channel, the global lipids market is segmented into direct tender, retail sales, and others. In 2023, the direct tender segment is expected to dominate the global lipids market with 9.4% in the forecast period of 2023 to 2030 due to being supplied directly from manufacturers or suppliers to large buyers, such as wholesalers, retailers, or institutional customers. This channel involves a bidding or procurement process where buyers directly negotiate and purchase lipids in large quantities.
Major Players
Data Bridge Market Research recognizes the following companies as the major lipids market players in Lipids market are Alnylam Pharmaceutical, Inc. (U.S.),Croda International Plc. (U.K.), Moderna Inc. (U.S.), BioNTech SE. (Germany), Pfizer Inc. (U.S.), Evonik Industries AG (Germany),Lipoid GmbH (Germany),Matreya LLC (U.S.), VAV Life Sciences Pvt Ltd. (India), Curia Global Inc. (U.S.)
Market Development
- In 2022, BioNTech SE announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. to acquire one of its GMP-certified manufacturing facilities.
- In 2021, U.S. ingredients supplier ABITEC Corporation signed an amended agreement with DKSH to distribute its specialty lipids into new markets and regions across Europe. This has helped the company to expand its business in various regions.
- In 2021, Merck scaled up the production of lipids to meet patients’ demands during COVID-19. The company launched a new, high-purity synthetic cholesterol product.
- In 2021, Evonik invested in the short-term growth of its specialty lipids production at its Hanau and Dossenheim locations in Germany, which supplied two of the four lipids for the Pfizer/BioNTech vaccine. According to Spencer, the first batches were delivered to BioNTech, months ahead of schedule.
Regional Analysis
Geographically, the countries covered in the lipids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
Asia Pacific is the dominant region in lipids market during the forecast period 2023 - 2030
In 2023, Asia Pacific emerged as the dominant region in the lipids industry, accounting for over 39.20% of the total revenue. This can be attributed to the growing demand for dietary supplements, functional food, functional beverages, and pharmaceuticals in the region. The COVID-19 pandemic has caused a shift in people's lifestyles and priorities, with consumers in Asia Pacific becoming more health-conscious. Consequently, the consumption of dietary supplements, functional foods, and medicines has witnessed significant growth and is expected to continue in the future.
North America is estimated to be the fastest-growing region in the lipids market the forecast period 2023 - 2030
The North America lipids market is poised for growth due to several factors. The region is witnessing a rise in chronic diseases, leading to an increased demand for pharmaceutical drugs, many of which utilize lipids as essential components. Additionally, there is a growing demand for lipids in various industries, such as food, cosmetics, and pharmaceuticals, further boosting the market. These factors, coupled with advancements in lipid research and technology, are expected to drive the growth of the North American lipids market in the forecasted period.
For more detailed information about the lipids market report, click here – https://www.databridgemarketresearch.com/reports/global-lipid-market
